Crenezumab (Anti-Amyloid Beta)
Product Specifications
CAS Number
1095207-05-8
Synonyms
MABT 5102A; RG 7412
SKU
C00532-1mg
Target
Beta Amyloid
Applications
Neuronal Signaling
Additionnal Information
Crenezumab (Anti-Amyloid Beta) is a fully humanized immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1367348-01 0.02 mg (E-Coli)
Recombinant Mouse N-acylneuraminate-9-phosphatase (Nanp)
Ask
View Details 
MBS1367348-02 0.1 mg (E-Coli)
Recombinant Mouse N-acylneuraminate-9-phosphatase (Nanp)
Ask
View Details 
MBS1367348-03 0.02 mg (Yeast)
Recombinant Mouse N-acylneuraminate-9-phosphatase (Nanp)
Ask
View Details 
MBS1367348-04 0.1 mg (Yeast)
Recombinant Mouse N-acylneuraminate-9-phosphatase (Nanp)
Ask
View Details MBS1367348-05 0.02 mg (Baculovirus)
Recombinant Mouse N-acylneuraminate-9-phosphatase (Nanp)
Ask
View Details MBS1367348-06 0.02 mg (Mammalian-Cell)
Recombinant Mouse N-acylneuraminate-9-phosphatase (Nanp)
Ask
View Details